The global surgical site infection control market reached a value of US$ 4.20 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 5.51 Billion by 2027, exhibiting a CAGR of 4.63% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Surgical site infection (SSI) control refers to various practices or measures employed to prevent infections among patients during their stay at the hospital. These infections occur after surgery in the operated part of the body, leading to poor wound healing and extended overnight stays for the treatment. SSI control is essential as these infections can be severe and affect tissues, organs, or implants. Some commonly used SSI control products include surgical drapes, gloves, hair covers, disinfectants, skin preparation solutions, scrubs, and medical nonwovens. In recent years, SSI control solutions have gained traction across the healthcare sector as they help prevent infections, enhance patient care quality, and improve surgical outcomes and success rates.
SSI control products assist in reducing the duration of hospital stays, eliminating the need for revision surgeries, and minimizing patient discomfort. As a result, the rising cases of hospital-acquired infections represent the primary factor driving the market growth. Besides this, the growing awareness regarding SSIs and the shifting focus toward infection prevention through proper control measures are augmenting the product demand. Additionally, there has been a significant increase in the prevalence of chronic conditions, such as cancer, gastrointestinal disorders, and cardiovascular diseases (CVDs), due to the aging population, sedentary lifestyles, and unhealthy eating habits. This, in confluence with the increasing number of patients undergoing surgical procedures, is accelerating the adoption of SSI control products. Furthermore, several favorable initiatives undertaken by the governing and non-governing agencies of various countries, such as the introduction of stringent guidelines and training programs focused on infection control practices, are catalyzing the market growth. Moreover, the rising integration of SSI control products with advanced technologies, improving healthcare infrastructure, and ongoing research and development (R&D) activities are some of the factors creating a positive market outlook.
The publisher provides an analysis of the key trends in each sub-segment of the global surgical site infection control market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, infection type, surgery type and end user.
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Mérieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Mölnlycke Health Care AB, Prescient Surgical, Steris Corporation.
Surgical site infection (SSI) control refers to various practices or measures employed to prevent infections among patients during their stay at the hospital. These infections occur after surgery in the operated part of the body, leading to poor wound healing and extended overnight stays for the treatment. SSI control is essential as these infections can be severe and affect tissues, organs, or implants. Some commonly used SSI control products include surgical drapes, gloves, hair covers, disinfectants, skin preparation solutions, scrubs, and medical nonwovens. In recent years, SSI control solutions have gained traction across the healthcare sector as they help prevent infections, enhance patient care quality, and improve surgical outcomes and success rates.
Surgical Site Infection Control Market Trends:
SSI control products assist in reducing the duration of hospital stays, eliminating the need for revision surgeries, and minimizing patient discomfort. As a result, the rising cases of hospital-acquired infections represent the primary factor driving the market growth. Besides this, the growing awareness regarding SSIs and the shifting focus toward infection prevention through proper control measures are augmenting the product demand. Additionally, there has been a significant increase in the prevalence of chronic conditions, such as cancer, gastrointestinal disorders, and cardiovascular diseases (CVDs), due to the aging population, sedentary lifestyles, and unhealthy eating habits. This, in confluence with the increasing number of patients undergoing surgical procedures, is accelerating the adoption of SSI control products. Furthermore, several favorable initiatives undertaken by the governing and non-governing agencies of various countries, such as the introduction of stringent guidelines and training programs focused on infection control practices, are catalyzing the market growth. Moreover, the rising integration of SSI control products with advanced technologies, improving healthcare infrastructure, and ongoing research and development (R&D) activities are some of the factors creating a positive market outlook.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global surgical site infection control market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, infection type, surgery type and end user.
Breakup by Product:
- Antibiotic Prophylaxis Products
- Wound Care Dressings
- Surgical Drapes
- Surgical Clippers
- Antiseptics and Disinfectants
- Wound Irrigation Products
- Others
Breakup by Infection Type:
- Superficial Incisional SSI
- Deep Incisional SSI
- Organ or Space SSI
Breakup by Surgery Type:
- Cesarean Section
- Gastric Bypass
- Cataract Surgery
- Dental Restoration
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Mérieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Mölnlycke Health Care AB, Prescient Surgical, Steris Corporation.
Key Questions Answered in This Report:
- How has the global surgical site infection control market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global surgical site infection control market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the infection type?
- What is the breakup of the market based on the surgery type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global surgical site infection control market and who are the key players?
- What is the degree of competition in the industry?
Frequently Asked Questions about the Global Surgical Site Infection Control Market
What is the estimated value of the Global Surgical Site Infection Control Market?
What is the growth rate of the Global Surgical Site Infection Control Market?
What is the forecasted size of the Global Surgical Site Infection Control Market?
Who are the key companies in the Global Surgical Site Infection Control Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | June 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 4.2 Billion |
| Forecasted Market Value ( USD | $ 5.5 Billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Surgical Site Infection Control Market
6 Market Breakup by Product
7 Market Breakup by Infection Type
8 Market Breakup by Surgery Type
9 Market Breakup by End User
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- 3M Company
- Ansell Limited
- Becton Dickinson and Company
- bioMerieux SA. (Institut Mérieux)
- Covalon Technologies Ltd.
- GAMA Healthcare Ltd.
- Getinge AB (Carl Bennet AB)
- Johnson & Johnson
- Kimberly-Clark Corporation
- Mölnlycke Health Care AB
- Prescient Surgical
- Steris Corporation.
Methodology
LOADING...
